Terms: = Brain cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Staging
3 results:
1. EORTC Lung cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.
Levy A; Hendriks LEL; Berghmans T; Faivre-Finn C; GiajLevra M; GiajLevra N; Hasan B; Pochesci A; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Besse B; Novello S; Dingemans AC;
Eur J Cancer; 2019 Nov; 122():109-114. PubMed ID: 31671363
[TBL] [Abstract] [Full Text] [Related]
2. miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting fasTK.
Zhi F; Zhou G; Shao N; Xia X; Shi Y; Wang Q; Zhang Y; Wang R; Xue L; Wang S; Wu S; Peng Y; Yang Y
PLoS One; 2013; 8(8):e72390. PubMed ID: 24013584
[TBL] [Abstract] [Full Text] [Related]
3. Intra- and interobserver variability of linear and volumetric measurements of brain metastases using contrast-enhanced magnetic resonance imaging.
Bauknecht HC; Romano VC; Rogalla P; Klingebiel R; Wolf C; Bornemann L; Hamm B; Hein PA
Invest Radiol; 2010 Jan; 45(1):49-56. PubMed ID: 19996757
[TBL] [Abstract] [Full Text] [Related]
